Studies on the total synthesis and evaluation of antitumor antibiotics including isochrysohermidin, streptonigrone, fredericamycin A, rubrolone, bleomycin A2 and key structural analogs are detailed. In the course of the studies, the investigation, development, and implementation of: (l) heteroaromatic azadiene Diels-Alder reactions, (2) the LUMO(diene)- controlled Diels-Alder reactions of N-sulfonyl-l-aza-l,3-butadienes, (3) the intramolecular Diels-Alder reactions of 0-methyl alpha-beta- unsaturated oximes, (4) the thermal reactions of cyclopropenone ketals including those of reversibly generated pi-delocalized singlet vinylcarbenes, (5) chromium carbene complex benzannulation reactions, and (6) acyl radical alkene addition reactions will continue to be pursued and provide the opportunity to comprehensively extend past studies. An additional application of the synthetic methodology to the preparation of pyridoxol is described. The proposed studies include the examination of antitumor antibiotics that mediate their cellular effects through sequence selective duplex DNA binding and modification and provide well-defined problems on the design, preparation, and evaluation of synthetic, mechanism-based antitumor agents in which fundamental studies of their structural responsible for DNA binding affinity, selectivity, and functional reactivity may be addressed.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA042056-12
Application #
2090582
Study Section
Medicinal Chemistry Study Section (MCHA)
Project Start
1986-02-01
Project End
1999-01-31
Budget Start
1995-02-01
Budget End
1996-01-31
Support Year
12
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Morin, Matthew D; Wang, Ying; Jones, Brian T et al. (2018) Diprovocims: A New and Exceptionally Potent Class of Toll-like Receptor Agonists. J Am Chem Soc 140:14440-14454
Wang, Ying; Su, Lijing; Morin, Matthew D et al. (2018) Adjuvant effect of the novel TLR1/TLR2 agonist Diprovocim synergizes with anti-PD-L1 to eliminate melanoma in mice. Proc Natl Acad Sci U S A 115:E8698-E8706
Glinkerman, Christopher M; Boger, Dale L (2018) Synthesis, Characterization, and Rapid Cycloadditions of 5-Nitro-1,2,3-triazine. Org Lett 20:2628-2631
Radakovic, Aleksandar; Boger, Dale L (2018) High expression of class III ?-tubulin has no impact on functional cancer cell growth inhibition of a series of key vinblastine analogs. Bioorg Med Chem Lett 28:863-865
Lukesh 3rd, John C; Carney, Daniel W; Dong, Huijun et al. (2017) Vinblastine 20' Amides: Synthetic Analogues That Maintain or Improve Potency and Simultaneously Overcome Pgp-Derived Efflux and Resistance. J Med Chem 60:7591-7604
Yang, Shouliang; Sankar, Kuppusamy; Skepper, Colin K et al. (2017) Total synthesis of a key series of vinblastines modified at C4 that define the importance and surprising trends in activity. Chem Sci 8:1560-1569
Allemann, Oliver; Cross, R Matthew; Brütsch, Manuela M et al. (2017) Key analogs of a uniquely potent synthetic vinblastine that contain modifications of the C20' ethyl substituent. Bioorg Med Chem Lett 27:3055-3059
Quiñones, Ryan E; Glinkerman, Christopher M; Zhu, Kaicheng et al. (2017) Direct Synthesis of ?-Aminoenals through Reaction of 1,2,3-Triazine with Secondary Amines. Org Lett 19:3568-3571
Boger, Dale L (2017) The Difference a Single Atom Can Make: Synthesis and Design at the Chemistry-Biology Interface. J Org Chem 82:11961-11980
Carney, Daniel W; Lukesh 3rd, John C; Brody, Daniel M et al. (2016) Ultrapotent vinblastines in which added molecular complexity further disrupts the target tubulin dimer-dimer interface. Proc Natl Acad Sci U S A 113:9691-8

Showing the most recent 10 out of 102 publications